Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics
Roche Holding AG (OTC:RHHBY) raised its 2021 sales forecast after posting an 8% rise in nine-month revenues, driven by demand…
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
AstraZeneca Plc (NASDAQ: AZN) has paused an active Phase 1 trial of AZD5991, a direct inhibitor of MCL-1, citing a potential safety issue.
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
Here's a roundup of top developments in the biotech space over the last 24 hours.
Roche’s Tecentriq Wins FDA Approval In Adjuvant Lung Cancer Setting
The FDA has greenlit Roche Holdings AG’s (OTC:RHHBY) Tecentriq and platinum-based chemotherapy as post-surgery treatment for non-small cell lung cancer with…
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
You can perch on a 1-legged stool and balance precariously on 2, but if you want to settle in with comfort and safety, you need 3 sturdy legs.
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours:
Sarepta’s Duchenne Gene Therapy Shows Sustained Functional Improvements
Sarepta Therapeutics Inc (NASDAQ:SRPT) shared new analyses and functional data from its SRP-9001 development program and the details of Study SRP-9001-301…
Roche’s Alzheimer’s Candidate Secures FDA Breakthrough Designation
Roche Holdings AG’s (OTC:RHHBY) gantenerumab antibody received breakthrough therapy designation from the FDA for Alzheimer’s disease. Gantenerumab is designed to neutralize…
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned.